Selected research
Market Analysis & Forecast
Global Autism Spectrum Disorder Screening Service Market Analysis and Forecast 2026-2032
Market perspective
The global Autism Spectrum Disorder Screening Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Autism Spectrum Disorder Screening Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Autism Spectrum Disorder Screening Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Autism Spectrum Disorder Screening Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Autism Spectrum Disorder Screening Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Autism Spectrum Disorder Screening Service include Autism Speaks, Mayo Clinic, Children's Hospital of Philadelphia, Kaiser Permanente, Cleveland Clinic, Mind Institute at UC Davis and Guangdong Jinglan Technology Industry Holding Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Autism Spectrum Disorder Screening Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Autism Spectrum Disorder Screening Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Autism Spectrum Disorder Screening Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Autism Spectrum Disorder Screening Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Autism Spectrum Disorder Screening Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Autism Spectrum Disorder Screening Service revenue, projected growth trends, production technology, application and end-user industry.
Autism Spectrum Disorder Screening Service Segment by Company
Autism Speaks
Mayo Clinic
Children's Hospital of Philadelphia
Kaiser Permanente
Cleveland Clinic
Mind Institute at UC Davis
Guangdong Jinglan Technology Industry Holding Group
Autism Spectrum Disorder Screening Service Segment by Type
Developmental Screening Service
Behavioral Assessment Service
Autism Spectrum Disorder Screening Service Segment by Application
Child
Aldult
Autism Spectrum Disorder Screening Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autism Spectrum Disorder Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autism Spectrum Disorder Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autism Spectrum Disorder Screening Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Autism Spectrum Disorder Screening Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Autism Spectrum Disorder Screening Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autism Spectrum Disorder Screening Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Developmental Screening Service
- Behavioral Assessment Service
Applications
- Child
- Aldult
Companies covered
- Autism Speaks
- Mayo Clinic
- Children's Hospital of Philadelphia
- Kaiser Permanente
- Cleveland Clinic
- Mind Institute at UC Davis
- Guangdong Jinglan Technology Industry Holding Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Autism Spectrum Disorder Screening Service Market by Type
- 1.2.1 Global Autism Spectrum Disorder Screening Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Developmental Screening Service
- 1.2.3 Behavioral Assessment Service
- 1.3 Autism Spectrum Disorder Screening Service Market by Application
- 1.3.1 Global Autism Spectrum Disorder Screening Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Child
- 1.3.3 Aldult
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Autism Spectrum Disorder Screening Service Market Dynamics
- 2.1 Autism Spectrum Disorder Screening Service Industry Trends
- 2.2 Autism Spectrum Disorder Screening Service Industry Drivers
- 2.3 Autism Spectrum Disorder Screening Service Industry Opportunities and Challenges
- 2.4 Autism Spectrum Disorder Screening Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Autism Spectrum Disorder Screening Service Market Perspective (2021-2032)
- 3.2 Global Autism Spectrum Disorder Screening Service Growth Trends by Region
- 3.2.1 Global Autism Spectrum Disorder Screening Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Autism Spectrum Disorder Screening Service Market Size by Region (2021-2026)
- 3.2.3 Global Autism Spectrum Disorder Screening Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Autism Spectrum Disorder Screening Service Revenue by Players
- 4.1.1 Global Autism Spectrum Disorder Screening Service Revenue by Players (2021-2026)
- 4.1.2 Global Autism Spectrum Disorder Screening Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Autism Spectrum Disorder Screening Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Autism Spectrum Disorder Screening Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Autism Spectrum Disorder Screening Service Key Players Headquarters & Area Served
- 4.4 Global Autism Spectrum Disorder Screening Service Players, Product Type & Application
- 4.5 Global Autism Spectrum Disorder Screening Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Autism Spectrum Disorder Screening Service Market CR5 and HHI
- 4.6.3 2025 Autism Spectrum Disorder Screening Service Tier 1, Tier 2, and Tier 3
5 Autism Spectrum Disorder Screening Service Market Size by Type
- 5.1 Global Autism Spectrum Disorder Screening Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Autism Spectrum Disorder Screening Service Revenue by Type (2021-2032)
- 5.3 Global Autism Spectrum Disorder Screening Service Revenue Market Share by Type (2021-2032)
6 Autism Spectrum Disorder Screening Service Market Size by Application
- 6.1 Global Autism Spectrum Disorder Screening Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Autism Spectrum Disorder Screening Service Revenue by Application (2021-2032)
- 6.3 Global Autism Spectrum Disorder Screening Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Autism Speaks
- 7.1.1 Autism Speaks Company Information
- 7.1.2 Autism Speaks Business Overview
- 7.1.3 Autism Speaks Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Autism Speaks Autism Spectrum Disorder Screening Service Product Portfolio
- 7.1.5 Autism Speaks Recent Developments
- 7.2 Mayo Clinic
- 7.2.1 Mayo Clinic Company Information
- 7.2.2 Mayo Clinic Business Overview
- 7.2.3 Mayo Clinic Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Mayo Clinic Autism Spectrum Disorder Screening Service Product Portfolio
- 7.2.5 Mayo Clinic Recent Developments
- 7.3 Children's Hospital of Philadelphia
- 7.3.1 Children's Hospital of Philadelphia Company Information
- 7.3.2 Children's Hospital of Philadelphia Business Overview
- 7.3.3 Children's Hospital of Philadelphia Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Children's Hospital of Philadelphia Autism Spectrum Disorder Screening Service Product Portfolio
- 7.3.5 Children's Hospital of Philadelphia Recent Developments
- 7.4 Kaiser Permanente
- 7.4.1 Kaiser Permanente Company Information
- 7.4.2 Kaiser Permanente Business Overview
- 7.4.3 Kaiser Permanente Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Kaiser Permanente Autism Spectrum Disorder Screening Service Product Portfolio
- 7.4.5 Kaiser Permanente Recent Developments
- 7.5 Cleveland Clinic
- 7.5.1 Cleveland Clinic Company Information
- 7.5.2 Cleveland Clinic Business Overview
- 7.5.3 Cleveland Clinic Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Cleveland Clinic Autism Spectrum Disorder Screening Service Product Portfolio
- 7.5.5 Cleveland Clinic Recent Developments
- 7.6 Mind Institute at UC Davis
- 7.6.1 Mind Institute at UC Davis Company Information
- 7.6.2 Mind Institute at UC Davis Business Overview
- 7.6.3 Mind Institute at UC Davis Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Mind Institute at UC Davis Autism Spectrum Disorder Screening Service Product Portfolio
- 7.6.5 Mind Institute at UC Davis Recent Developments
- 7.7 Guangdong Jinglan Technology Industry Holding Group
- 7.7.1 Guangdong Jinglan Technology Industry Holding Group Company Information
- 7.7.2 Guangdong Jinglan Technology Industry Holding Group Business Overview
- 7.7.3 Guangdong Jinglan Technology Industry Holding Group Autism Spectrum Disorder Screening Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Guangdong Jinglan Technology Industry Holding Group Autism Spectrum Disorder Screening Service Product Portfolio
- 7.7.5 Guangdong Jinglan Technology Industry Holding Group Recent Developments
8 North America
- 8.1 North America Autism Spectrum Disorder Screening Service Revenue (2021-2032)
- 8.2 North America Autism Spectrum Disorder Screening Service Revenue by Type (2021-2032)
- 8.2.1 North America Autism Spectrum Disorder Screening Service Revenue by Type (2021-2026)
- 8.2.2 North America Autism Spectrum Disorder Screening Service Revenue by Type (2027-2032)
- 8.3 North America Autism Spectrum Disorder Screening Service Revenue Share by Type (2021-2032)
- 8.4 North America Autism Spectrum Disorder Screening Service Revenue by Application (2021-2032)
- 8.4.1 North America Autism Spectrum Disorder Screening Service Revenue by Application (2021-2026)
- 8.4.2 North America Autism Spectrum Disorder Screening Service Revenue by Application (2027-2032)
- 8.5 North America Autism Spectrum Disorder Screening Service Revenue Share by Application (2021-2032)
- 8.6 North America Autism Spectrum Disorder Screening Service Revenue by Country
- 8.6.1 North America Autism Spectrum Disorder Screening Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Autism Spectrum Disorder Screening Service Revenue by Country (2021-2026)
- 8.6.3 North America Autism Spectrum Disorder Screening Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Autism Spectrum Disorder Screening Service Revenue (2021-2032)
- 9.2 Europe Autism Spectrum Disorder Screening Service Revenue by Type (2021-2032)
- 9.2.1 Europe Autism Spectrum Disorder Screening Service Revenue by Type (2021-2026)
- 9.2.2 Europe Autism Spectrum Disorder Screening Service Revenue by Type (2027-2032)
- 9.3 Europe Autism Spectrum Disorder Screening Service Revenue Share by Type (2021-2032)
- 9.4 Europe Autism Spectrum Disorder Screening Service Revenue by Application (2021-2032)
- 9.4.1 Europe Autism Spectrum Disorder Screening Service Revenue by Application (2021-2026)
- 9.4.2 Europe Autism Spectrum Disorder Screening Service Revenue by Application (2027-2032)
- 9.5 Europe Autism Spectrum Disorder Screening Service Revenue Share by Application (2021-2032)
- 9.6 Europe Autism Spectrum Disorder Screening Service Revenue by Country
- 9.6.1 Europe Autism Spectrum Disorder Screening Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Autism Spectrum Disorder Screening Service Revenue by Country (2021-2026)
- 9.6.3 Europe Autism Spectrum Disorder Screening Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Autism Spectrum Disorder Screening Service Revenue (2021-2032)
- 10.2 China Autism Spectrum Disorder Screening Service Revenue by Type (2021-2032)
- 10.2.1 China Autism Spectrum Disorder Screening Service Revenue by Type (2021-2026)
- 10.2.2 China Autism Spectrum Disorder Screening Service Revenue by Type (2027-2032)
- 10.3 China Autism Spectrum Disorder Screening Service Revenue Share by Type (2021-2032)
- 10.4 China Autism Spectrum Disorder Screening Service Revenue by Application (2021-2032)
- 10.4.1 China Autism Spectrum Disorder Screening Service Revenue by Application (2021-2026)
- 10.4.2 China Autism Spectrum Disorder Screening Service Revenue by Application (2027-2032)
- 10.5 China Autism Spectrum Disorder Screening Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Autism Spectrum Disorder Screening Service Revenue (2021-2032)
- 11.2 Asia Autism Spectrum Disorder Screening Service Revenue by Type (2021-2032)
- 11.2.1 Asia Autism Spectrum Disorder Screening Service Revenue by Type (2021-2026)
- 11.2.2 Asia Autism Spectrum Disorder Screening Service Revenue by Type (2027-2032)
- 11.3 Asia Autism Spectrum Disorder Screening Service Revenue Share by Type (2021-2032)
- 11.4 Asia Autism Spectrum Disorder Screening Service Revenue by Application (2021-2032)
- 11.4.1 Asia Autism Spectrum Disorder Screening Service Revenue by Application (2021-2026)
- 11.4.2 Asia Autism Spectrum Disorder Screening Service Revenue by Application (2027-2032)
- 11.5 Asia Autism Spectrum Disorder Screening Service Revenue Share by Application (2021-2032)
- 11.6 Asia Autism Spectrum Disorder Screening Service Revenue by Country
- 11.6.1 Asia Autism Spectrum Disorder Screening Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Autism Spectrum Disorder Screening Service Revenue by Country (2021-2026)
- 11.6.3 Asia Autism Spectrum Disorder Screening Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Autism Spectrum Disorder Screening Service Revenue (2021-2032)
- 12.2 SAMEA Autism Spectrum Disorder Screening Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Autism Spectrum Disorder Screening Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Autism Spectrum Disorder Screening Service Revenue by Type (2027-2032)
- 12.3 SAMEA Autism Spectrum Disorder Screening Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Autism Spectrum Disorder Screening Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Autism Spectrum Disorder Screening Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Autism Spectrum Disorder Screening Service Revenue by Application (2027-2032)
- 12.5 SAMEA Autism Spectrum Disorder Screening Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Autism Spectrum Disorder Screening Service Revenue by Country
- 12.6.1 SAMEA Autism Spectrum Disorder Screening Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Autism Spectrum Disorder Screening Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Autism Spectrum Disorder Screening Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst